The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Toward more realistic drug-target interaction predictions
Open accessAbstract
A number of supervised machine learning models have recently been introduced for the prediction of drug-target interactions based on chemical structure and genomic sequence information. Although these models could offer improved means for many network pharmacology applications, such as repositioning of drugs for new therapeutic uses, the prediction models are often being constructed and evaluated under overly simplified settings that do not reflect the real-life problem in practical applications. Using quantitative drug-target bioactivity assays for kinase inhibitors, as well as a popular benchmarking data set of binary drug-target interactions for enzyme, ion channel, nuclear receptor and G protein-coupled receptor targets, we illustrate here the effects of four factors that may lead to dramatic differences in the prediction results: (i) problem formulation (standard binary classification or more realistic regression formulation), (ii) evaluation data set (drug and target families in the application use case), (iii) evaluation procedure (simple or nested cross-validation) and (iv) experimental setting (whether training and test sets share common drugs and targets, only drugs or targets or neither). Each of these factors should be taken into consideration to avoid reporting overoptimistic drug-target interaction prediction results. We also suggest guidelines on how to make the supervised drug-target interaction prediction studies more realistic in terms of such model formulations and evaluation setups that better address the inherent complexity of the prediction task in the practical applications, as well as novel benchmarking data sets that capture the continuous nature of the drug-target interactions for kinase inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Predicting new molecular targets for rhein using network pharmacology
Zhang, A., Sun, H. J., Yang, B., & Wang, X. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-20 · Cited by 47
RetractedPan, S. J., & Yang, Q. (2010) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2009.191 · Cited by 23,387
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Hawkins, D. M. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0342472 · Cited by 2,522
Bias in error estimation when using cross-validation for model selection
Varma, S., & Simon, R. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-91 · Cited by 2,485 · cited 2×
“In addition to the aforementioned CV issues, selection of hyper-parameters, such as the regularization [20–23] that if CV estimate is used as a parameter selection tool, the same estimate is no longer reliable for estimating the prediction performance of the model trained with the optimal…”
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Selection bias in gene extraction on the basis of microarray gene-expression data
Ambroise, C., & McLachlan, G. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102102699 · Cited by 1,480
Prediction of drug–target interaction networks from the integration of chemical and genomic spaces
Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,147
Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification
Simon, R., Radmacher, M. D., Dobbin, K., & McShane, L. M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.14 · Cited by 1,006
Gaussian interaction profile kernels for predicting drug–target interaction
van Laarhoven, T., Nabuurs, S. B., & Marchiori, E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr500 · Cited by 934
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Zhou, W., Huang, J., & Tang, Y. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002503 · Cited by 818
Concordance probability and discriminatory power in proportional hazards regression
Gönen, M., & Heller, G. (2005) · Biometrika · doi:10.1093/biomet/92.4.965 · Cited by 673
Tang, J., Szwajda, A., Shakyawar, S., Xu, T., Hintsanen, P., Wennerberg, K., & Aittokallio, T. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400709d · Cited by 645
Self-citationSupervised prediction of drug–target interactions using bipartite local models
Bleakley, K., & Yamanishi, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp433 · Cited by 628
Menden, M. P., Iorio, F., Garnett, M., McDermott, U., Benes, C. H., Ballester, P. J., & Saez-Rodriguez, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061318 · Cited by 542
Shaping the interaction landscape of bioactive molecules
Gfeller, D., Michielin, O., & Zoete, V. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt540 · Cited by 501
Hattori, M., Okuno, Y., Goto, S., & Kanehisa, M. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036030u · Cited by 484
Yamanishi, Y., Kotera, M., Kanehisa, M., & Goto, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq176 · Cited by 470
Similarity-based machine learning methods for predicting drug–target interactions: a brief review
Ding, H., Takigawa, I., Mamitsuka, H., & Zhu, S. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbt056 · Cited by 427
Yu, H., Chen, J., Xu, X., Li, Y., Zhao, H., Fang, Y., Li, X., Zhou, W., Wang, W., & Wang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037608 · Cited by 423
Gönen, M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts360 · Cited by 383
Drug–target interaction prediction by learning from local information and neighbors
Mei, J.-P., Kwoh, C.-K., Yang, P., Li, X.-L., & Zheng, J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts670 · Cited by 382
Metz, J. T., Johnson, E. F., Soni, N. B., Merta, P. J., Kifle, L., & Hajduk, P. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.530 · Cited by 311
Similarity to Molecules in the Training Set Is a Good Discriminator for Prediction Accuracy in QSAR
Sheridan, R. P., Feuston, B. P., Maiorov, V. N., & Kearsley, S. K. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci049782w · Cited by 298
Rogers, D., Brown, R. D., & Hahn, M. (2005) · SLAS Discovery · doi:10.1177/1087057105281365 · Cited by 296
Koutsoukas, A., Simms, B., Kirchmair, J., Bond, P. J., Whitmore, A. V., Zimmer, S., Young, M. P., Jenkins, J. L., Glick, M., Glen, R. C., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.011 · Cited by 287
Drug repositioning for personalized medicine
Li, Y. Y., & Jones, S. J. (2012) · Genome Medicine · doi:10.1186/gm326 · Cited by 248
Combining Drug and Gene Similarity Measures for Drug-Target Elucidation
Perlman, L., Gottlieb, A., Atias, N., Ruppin, E., & Sharan, R. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0213 · Cited by 218
Flaws in evaluation schemes for pair-input computational predictions
Park, Y., & Marcotte, E. M. (2012) · Nature Methods · doi:10.1038/nmeth.2259 · Cited by 209
Xie, L., Xie, L., Kinnings, S. L., & Bourne, P. E. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134630 · Cited by 202
Pitfalls of supervised feature selection
Smialowski, P., Frishman, D., & Kramer, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp621 · Cited by 197
Tang, J., & Aittokallio, T. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990470 · Cited by 175
Self-citationAirola, A., Pahikkala, T., Waegeman, W., De Baets, B., & Salakoski, T. (2011) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2010.11.018 · Cited by 166
Self-citationA Computational Approach to Finding Novel Targets for Existing Drugs
Li, Y. Y., An, J., & Jones, S. J. M. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002139 · Cited by 129
Cheng, F., Zhou, Y., Li, J., Li, W., Liu, G., & Tang, Y. (2012) · Molecular BioSystems · doi:10.1039/c2mb25110h · Cited by 115
Large‐scale prediction of drug–target relationships
Kuhn, M., Campillos, M., González, P., Jensen, L. J., & Bork, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.024 · Cited by 93
Kernel-based data fusion improves the drug–protein interaction prediction
Wang, Y., Zhang, C., Deng, N.-Y., & Wang, Y. (2011) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2011.10.003 · Cited by 70
Biochemical network-based drug-target prediction
Klipp, E., Wade, R. C., & Kummer, U. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.05.004 · Cited by 68
Network predicting drug’s anatomical therapeutic chemical code
Wang, Y., Chen, S., Deng, N.-Y., & Wang, Y. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt158 · Cited by 53
Chemogenomic Approaches to Infer Drug–Target Interaction Networks
Yamanishi, Y. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-107-3_9 · Cited by 50
Pahikkala, T., Okser, S., Airola, A., Salakoski, T., & Aittokallio, T. A. (2012) · Algorithms for Molecular Biology · doi:10.1186/1748-7188-7-11 · Cited by 34
Self-citationEfficient regularized least-squares algorithms for conditional ranking on relational data
Pahikkala, T., Airola, A., Stock, M., Bernard De Baets, C., & Waegeman, W. (2013) · Machine Learning · doi:10.1007/s10994-013-5354-7 · Cited by 33
Self-citationCOPICAT: a software system for predicting interactions between proteins and chemical compounds
Sakakibara, Y., Hachiya, T., Uchida, M., et al. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts031 · Cited by 18
Predicting drug–target interactions through integrative analysis of chemogenetic assays in yeast
Heiskanen, M. A., & Aittokallio, T. A. (2013) · Molecular BioSystems · doi:10.1039/c3mb25591c · Cited by 6
Self-citation
Cited by
DeepDTA: deep drug–target binding affinity prediction
Öztürk, H., Özgür, A., & Ozkirimli, E. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty593 · Cited by 1,696
Counting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Beck, B. R., Shin, B., Choi, Y., Park, S., & Kang, K. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.025 · Cited by 816
Drug–target interaction prediction: databases, web servers and computational models
Chen, X., Yan, C. C., Zhang, X., Zhang, X., Dai, F., Yin, J., & Zhang, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv066 · Cited by 658
DeepSynergy: predicting anti-cancer drug synergy with Deep Learning
Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx806 · Cited by 653
Metadata
- Authors
- Pahikkala, T., Airola, A., Pietila, S., Shakyawar, S., Szwajda, A., Tang, J., & Aittokallio, T.
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04-09
- Volume
- 16
- Issue
- 2
- Pages
- 325-337
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W2109991441
- Cited by
- 559
- References
- 46
- FWCI
- 18.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.